Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue SUPPL.2, 2012, Pages 63-69

  Carratalà, Jordi ^a   Montejo, Miguel ^b   Pérez Romero, Pilar ^c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Epstein Barr virus; Herpes simplex virus; Other human herpes viruses; Post transplant lymphoproliferative disorder; Solid organ transplantation; Varicella zoster virus

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BASILIXIMAB; CIDOFOVIR; CYCLOSPORIN; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; OKT 3; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; TRIFLURIDINE; VALACICLOVIR; VALGANCICLOVIR;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CHICKENPOX; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA VIRUS; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HERPES LABIALIS; HERPES SIMPLEX; HERPES VIRUS; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIMARY EFFUSION LYMPHOMA; VARICELLA ZOSTER VIRUS;

EPSTEIN-BARR VIRUS INFECTIONS; HERPES ZOSTER; HERPESVIRIDAE INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 84860461209     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(12)70084-8     Document Type: Article

References (69)

1. F. Xu, M.R. Sternberg, B.J. Kottiri, G.M. McQuillan, F.K. Lee, and A.J. Nahmias Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 2006 964 973
2. W.J. Griffiths, T.G. Wreghitt, and G.J. Alexander Reactivation of herpes simplex virus after liver transplantation Transplantation 80 2005 1353 1354
3. N. Singh, J.S. Dummer, S. Kusne, M.K. Breinig, J.A. Armstrong, and L. Makowka Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: Transmission by donated organ and the effect of OKT3 antibodies J Infect Dis 158 1988 124 131
4. J.S. Dummer, J. Armstrong, J. Somers, S. Kusne, B.J. Carpenter, and J.T. Rosenthal Transmission of infection with herpes simplex virus by renal transplantation J Infect Dis 155 1987 202 206
5. I.Y. Tang, M.S. Maddux, S.A. Veremis, W.D. Bauma, R. Pollak, and M.F. Mozes Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy Transplant Proc 21 1989 1758 1760
6. C. Buell, and J. Koo Long-term safety of mycophenolate mofetil and cyclosporine: A review J Drugs Dermatol 7 2008 741 748
7. L. Seale, C.J. Jones, S. Kathpalia, G.G. Jackson, M. Mozes, and M.S. Maddux Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir JAMA 254 1985 3435 3438
8. Y.N. Kang, H.K. Oh, Y.C. Chang, H.C. Kim, S.L. Lee, and M. Hwang Systemic herpes simplex virus infection following cadaveric renal transplantation: A case report Transplant Proc 38 2006 1346 1347
9. M. Aguilar-Guisado, J. Gavaldà, P. Ussetti, A. Ramos, P. Morales, and M. Blanes Pneumonia after lung transplantation in the RESITRA Cohort: A multicenter prospective study Am J Transplant 7 2007 1989 1996
10. R. Zuckerman, and A. Wald The AST Infectious Diseases Community of Practice. Herpes simplex virus infections in solid organ transplant recipients Am J Transplant 9 Suppl 4 2009 S104 S107
11. D.H. Gilden, B.K. Kleinschmidt-DeMasters, J.J. LaGuardia, R. Mahalingam, and R.J. Cohrs Neurologic complications of the reactivation of varicella-zoster virus N Engl J Med 342 2000 635 645
12. S. Gourishankar, J.C. McDermid, G.S. Jhangri, and J.K. Preiksaitis Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era Am J Transplant 4 2004 108 115
13. J.W. Gnann Jr., and R.J. Whitley Clinical practice. Herpes zoster N Engl J Med 347 2002 340 346
14. O. Manuel, D. Kumar, L.G. Singer, I. Cobos, and A. Humar Incidence and clinical characteristics of herpes zoster after lung transplantation J Heart Lung Transplant 27 2008 11 16
15. A. Wald, M.L. Huang, D. Carrell, S. Selke, and L. Corey Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: Comparison with HSV isolation in cell culture J Infect Dis 188 2003 1345 1351
16. D.H. Shepp, P.S. Dandliker, and J.D. Meyers Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine N Engl J Med 314 1986 208 212
17. S.A. Pergam Limaye AP and the ATS Infectious Diseases Community of Practice. Varicella-zoster virus (VZV) in solid organ transplant recipients Am J Transplant 9 Suppl 4 2009 S108 S115
18. L.J. Vales-Albertos, J. Andrade-Sierra, B. Gómez-Navarro, F. Monteón-Ramos, M. Rodríguez-Pérez, and C. Torres-Lozano Nonspecific immunoglobulin and granulocytemacrophage colony-stimulating factor use in complicated varicella zoster: The first case report in a renal transplant recipient Transplantation 81 2006 809 810
19. A. Geel, W. Zuidema, T. Van Gelder, G. Van Doornum, and W. Weimar Successful vaccination against varicella zoster virus prior to kidney transplantation Transplant Proc 37 2005 952 953
20. S. Khan, J. Erlichman, and E. Rand Live virus immunization after orthotopic liver transplantation Pediatr Transplant 10 2006 78 82
21. U.D. Allen The ABC of Epstein-Barr virus infections Adv Exp Med Biol. 568 2005 25 39
22. G. Opelz, and B. Döhler Lymphomas after solid organ transplantation: A collaborative transplant study report Am J Transplant 4 2004 222 230
23. I.M. Ghobrial, T.M. Habermann, W.R. Macon, K.M. Ristow, T.S. Larson, and R.C. Walker Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases? Transplantation 79 2005 244 247
24. U. Allen, and J. Preiksaitis The AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients Am J Transplant 9 Suppl 4 2009 S87 S96
25. R.T. Hayden, K.M. Hokanson, S.B. Pounds, M.J. Bankowski, S.W. Belzer, and J. Carr Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus J Clin Microbiol 46 2008 157 163
26. D.P. Funch, A.M. Walker, G. Schneider, N.J. Ziyadeh, and M.D. Pescovitz Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients Am J Transplant 5 2005 2894 2900
27. S.J. Stevens, E.A. Verschuuren, S.A. Verkuujlen, A.J. Van Den Brule, C.J. Meijer, and J.M. Middeldorp Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease Leuk Lymphoma 43 2002 831 840
28. M. Green, M.G. Michaels, B.Z. Katz, M. Burroughs, D. Gerber, and B.L. Shneider CMVIVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients Am J Transplant 6 2006 1906 1912
29. J.W. Van Esser, H.G. Niesters, B. Van der Holt, E. Meijer, A.D. Osterhaus, and J.W. Gratama Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation Blood 99 2002 4364 4369
30. M. Green Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation Am J Transplant 1 2001 103 108
31. J.J. Lee, M.S. Lam, and A. Rosenberg Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation Ann Pharmacother 41 2007 1648 1659
32. C.B. Hall, C.E. Long, K.C. Schnabel, M.T. Caserta, K.M. McIntyre, and M.A. Costanzo Human herpesvirus-6 infection in children. A prospective study of complications and reactivation N Engl J Med 331 1994 432 438
33. F. Santoro, P.E. Kennedy, G. Locatelli, M.S. Malnati, E.A. Berger, and P. Lusso CD46 is a cellular receptor for human herpesvirus 6 Cell 99 1999 817 827
34. A. Simmons, Y. Demmrich, A. La Vista, and K. Smith Replication of human herpesvirus 6 in epithelial cells in vitro J Infect Dis 166 1992 202 205
35. A. Humar, M. Michaels AST ID Working Group on Infectious Disease Monitoring American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Am J Transplant 6 2006 262 274
36. D.H. Dockrell, and C.V. Paya Human herpesvirus-6 and -7 in transplantation Rev Med Virol 11 2001 23 36
37. V.C. Emery Human herpesviruses 6 and 7 in solid organ transplant recipients Clin Infect Dis 32 2001 1357 1360
38. D.M. Zerr, L. Corey, H.W. Kim, M.-L. Huang, L. Nguy, and M. Boeckh Clinical outcome of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation Clin Infect Dis 40 2005 932 940
39. I. Lautenschlager, K. Hockerstedt, K. Linnavuori, and E. Taskinen Human herpesvirus-6 infection after liver transplantation Clin Infect Dis 26 1998 702 707
40. K.N. Ward, J.J. Gray, and S. Efstathiou Brief report: Primary human herpesvirus 6 infection in a patient after liver transplantation from a seropositive donor J Med Virol 28 1989 69 72
41. P.S. Randhawa, F.J. Jenkins, M.A. Nalesnik, J. Martens, P.A. Williams, and A. Ries Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium Am J Surg Pathol 21 1997 847 853
42. D.L. Paterson, N. Singh, T. Gayowski, D.R. Carrigan, and I.R. Marino Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient Liver Transpl Surg 5 1999 454 455
43. W.W. Seeley, F.M. Marty, T.M. Holmes, K. Upchurch, R.J. Soiffer, and J.H. Antin Posttransplant acute limbic encephalitis: Clinical features and relationship to HHV6 Neurology 69 2007 156 165
44. A. Humar, G. Malkan, G. Moussa, P. Greig, G. Levy, and T. Mazzulli Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients J Infect Dis 181 2000 1450 1453
45. N. Singh, D.R. Carrigan, T. Gayowski, and I.R. Marino Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity Transplantation 64 1997 674 678
46. N. Singh, and D.R. Carrigan Human herpesvirus-6 in transplantation: An emerging pathogen Ann Intern Med 124 1996 1065 1071
47. R.R. Razonable, C. Fanning, R.A. Brown, M.J. Espy, A. Rivero, and J. Wilson Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts J Infect Dis 185 2002 110 113
48. A. Humar, D. Kumar, A.M. Caliendo, G. Moussa, A. Ashi-Sulaiman, G. Levy, and T. Mazzulli Clinical impact of human herpesvirus 6 infection after liver transplantation Transplantation 73 2002 599 604
49. S. Torigoe, T. Kumamoto, W. Koide, K. Taya, and K. Yamanishi Clinical manifestations associated with human herpesvirus 7 infection Arch Dis Child 72 1995 518 519
50. U.D. Allen Human herpesvirus type 8 infections among solid organ transplant recipients Pediatr Transplant 6 2002 187 192
51. W. Hladik, S.C. Dollard, J. Mermin, A.L. Fowlkes, R. Downing, and M.M. Amin Transmission of human herpesvirus 8 by blood transfusion N Engl J Med 355 2006 1331 1338
52. N. Regamey, M. Tamm, M. Wernli, A. Witschi, G. Thiel, and G. Cathomas Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients N Engl J Med 339 1998 1358 1363
53. E. Cesarman, Y. Chang, P.S. Moore, J.W. Said, and D.M. Knowles Kaposi's sarcoma-associated herpesvirus like DNA sequences in AIDS-related body-cavity-based lymphomas N Engl J Med 332 1995 1186 1191
54. Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, and D.M. Knowles Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
55. J. Soulier, L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, and P. Babinet Kaposi's sarcoma associated herpesvirus-like DNA sequences in multicentric Castleman's disease Blood 86 1995 1276 1280
56. P. Cattani, M. Capuano, R. Graffeo, R. Ricci, F. Cerimele, and D. Cerimele Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients J Clin Microbiol 39 2001 506 508
57. R. Sarid, G. Pizov, D. Rubinger, R. Backenroth, M.M. Friedlaender, and F. Schwartz Detection of human herpesvirus-8 DNA in kidney allografts prior to the development of Kaposi's sarcoma Clin Infect Dis 32 2001 1502 1505
58. G. Tessari, L. Naldi, L. Boschiero, C. Cordiano, S. Piaserico, and A.B. Fortina Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: A multicenter study Eur J Dermatol 16 2006 553 557
59. E.S. Woodle, M. Hanaway, J. Buell, T. Gross, M.R. First, and J. Trofe Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry Transplant Proc 33 2001 3660 3661
60. P. Aseni, M. Vertemati, E. Minola, C. Arcieri, E. Bonacina, and M. Camozzi Kaposi's sarcoma in liver transplant recipients: Morphological and clinical description Liver Transpl 7 2001 816 823
61. J.P. Emond, A.G. Marcelin, R. Dorent, C. Milliancourt, N. Dupin, and C. Frances Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients J Clin Microbiol 40 2002 2217 2219
62. C. Francès, C. Mouquet, A.G. Marcelin, S. Barete, R. Agher, and D. Charron Outcome of kidney transplant recipients with previous human herpesvirus-8 infection Transplantation 69 2000 1776 1779
63. L. Sarmati Serological testing for human herpesvirus 8 Herpes 8 2001 76 79
64. K. Antman, and Y. Chang Kaposi's sarcoma N Engl J Med 342 2000 1027 1038
65. C. Casper Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection Herpes 13 2006 42 47
66. D.H. Kedes, and D. Ganem Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy J Clin Invest 99 1997 2082 2086
67. R.N. Shaw, J.L. Arbiser, and M.K. Offermann Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells AIDS 14 2000 899 902
68. J.M. Campistol, A. Gutiérrez-Dalmau, and J.V. Torregrosa Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma Transplantation 77 2004 760 762
69. G. Stallone, A. Schena, B. Infante, S. Di Paolo, A. Loverre, and G. Maggio Sirolimus for Kaposi' s sarcoma in renal-transplant recipients N Engl J Med 352 2005 1317 1323